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Abstract 
We aimed to assess prevalence, birth outcome, associated anomalies and prenatal diagnosis of 
congenital clubfoot in Europe using data from the EUROCAT network, and to validate the recording 
of congenital clubfoot as a major congenital anomaly by EUROCAT registries. Cases of congenital 
clubfoot were included from 18 EUROCAT registries covering more than 4.8 million births in 1995-
2011. Cases without chromosomal anomalies born during 2005-2009, were randomly selected for 
validation using a questionnaire on diagnostic details and treatment. There was 5,458 congenital 
clubfoot cases of which 5056 (93%) were liveborn infants. Total prevalence of congenital clubfoot 
was 1.13 per 1000 births (95% CI 1.10-1.16). Prevalence of congenital clubfoot without chromosomal 
anomaly was 1.08 per 1000 births (95% CI 1.05-1.11) and prevalence of isolated congenital clubfoot 
was 0.92 per 1000 births (95% CI 0.90–0.95), both with decreasing trends over time and large 
variations in prevalence by registry . The majority of cases were isolated congenital clubfoot (82%) 
and 11% had associated major congenital anomalies. Prenatal detection rate of isolated congenital 
clubfoot was 22% and increased over time.  Among 301 validated congenital clubfoot cases, 
diagnosis was confirmed for 286 (95%). In conclusion, this large population-based study found a 
decreasing trend of congenital clubfoot in Europe after 1999-2002, an increasing prenatal detection 
rate, and a high standard of coding of congenital clubfoot in EUROCAT.  
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Introduction 
Congenital clubfoot, congenital talipes equinovarus, is one of the more common major congenital 
anomalies  with a prevalence of around 1 per 1000 livebirths [Parker et al, 2009]. Clubfoot is a 
congenital anomaly of several tissues of the foot and ankle, with one or both feet turning inward and 
downward.  Congenital clubfoot is clinically differentiated from postural clubfoot, a postnatally 
reduced positional defect. In congenital clubfoot, the foot cannot be moved into a normal position by 
hand.  Treatment of congenital clubfoot includes the Ponseti method with multiple casting or 
splinting, and/or surgery (Dobbs et al, 2000, Ganesan et al, 2017). The prevalence of congenital 
clubfoot has been reported as higher in males compared to females (2.0-2.5 times) [Kancherla et al, 
2010; Moorthi et al, 2005]. In about half of the patients, the anomaly is bilateral, and for unilateral 
clubfoot, the right side is affected slightly more frequently than the left side [Cardy et al, 2011]. 
Congenital clubfoot develops early in pregnancy and it can be detected by ultrasound from 12 weeks 
of gestation [Keret et al, 2002].  The overall rate of prenatal detection of congenital clubfoot was 
reported to be around 60% in three states of the USA in 2006-2011 [Mahan et al, 2014]. The prenatal 
detection rate was higher in cases associated with other anomalies [Mahan et al, 2014; Offerdal et al, 
2007; Seravalli et al, 2015].  
 
The etiology of congenital clubfoot is thought to be a combination of genetic and environmental 
factors. It has higher recurrence within families, however a twin study suggested that environmental 
factors also play a significant role in the etiology of congenital clubfoot [Engell et al, 2014]. Several 
environmental risk factors, in particular maternal smoking, have been related to the risk of 
congenital clubfoot [Pavone et al, 2018, Werler et al, 2015]. Some maternal medical conditions and 
medication use could increase the risk of congenital clubfoot, such as obesity (Werler et al, 2013] and 
use of selective serotonin reuptake inhibitors (SSRI) [Yazdy et al, 2014; Wemakor et al, 2015].  In a 
EUROCAT study investigating lamotrigine exposure associated with an increased risk for orofacial 
clefts, there was an unexplained excess risk of congenital clubfoot among lamotrigine-exposed 
pregnancies [Dolk et al, 2008].  
 
The aim of the current study was to estimate the prevalence, trend over time, prenatal diagnosis and 
associated anomalies of congenital clubfoot in Europe using data from a population-based 
surveillance program of congenital anomalies (EUROCAT), 1995-2011. In addition, this study aims to 
validate the registration of congenital clubfoot as a major congenital anomaly by EUROCAT registries. 
 
Methods 
The EUROCAT registries are population-based congenital anomaly registries in Europe, covering 
about 30% of the European birth population. Details of the EUROCAT database and the methods of 
case ascertainment have been described previously {Dolk et al, 2008]. In brief, congenital anomalies 
in livebirths, fetal deaths including stillbirths and spontaneous abortions from gestational age (GA) 20 
weeks, and terminations of pregnancy following prenatal diagnosis at any GA (TOPFA) were recorded 
in the EUROCAT database, according to the EUROCAT Guides {EUROCAT website). The inclusion 
criteria for the EUROCAT database is a code within the congenital anomaly chapter in ICD9 (740-759) 
or in ICD10 (Q-chapter). One syndrome and up to eight congenital anomalies per baby/fetus can be 
registered in the EUROCAT database with ICD9 or ICD10 codes with the British Paediatric Association 
extensions. Additional information can be added in a text variable.  Anomalies on the EUROCAT list of 
minor anomalies are not included if isolated. Clubfoot of postural origin is on the list of minors for 
exclusion (Q668). Information on anomalies was obtained from multiple sources, including hospital 
records, birth and death certificates and post-mortem examinations [Greenlees et al, 2011]. The 
follow-up period for inclusion of congenital anomalies in the EUROCAT varies among registries: the 
diagnosis of a congenital anomaly is up to one year of age in most registries. The current study 
included data from 18 registries, covering a total of 4,840,588 births in the period of 1995-2011.   
 
All cases of the EUROCAT subgroup “clubfoot”, based on the ICD 9  code 75450 or ICD 10 code Q660, 
were extracted from the central EUROCAT database (n=5,810). A total of 352 cases were excluded as 
the clubfoot was secondary to another primary anomaly: neural tube defect (NTD), bilateral renal 
agenesis, Potter sequence or arthrogryposis multiplex congenital [Garne et al, 2011], since these 
would be etiologically different. There was large variation in the proportion of cases with secondary 
clubfoot excluded by registry (Data in Appendix). 
 A computer algorithm was used to classify the remaining infants and fetuses with congenital 
clubfoot into isolated, potential multiple congenital anomaly, genetic syndrome, teratogenic 
syndrome and chromosomal anomaly [Garne et al, 2011]. All potential multiple congenital anomaly 
cases were manually reviewed by a paediatrician (EG) and checked by a geneticist (IB). The potential 
multiple cases were re-classified as true multiple congenital anomaly or re-classified to another 
group.  
 The trend analysis and the validation study included all infants and fetuses that did not have a 
chromosomal anomaly (non-chromosomal).  
Validation study of clubfoot records in EUROCAT 
Twenty infants with congenital clubfoot or all infants if less than 20 in the period from 2005 up to 
2009, were randomly selected from 16 registries participating in the validation study. Registries in 
Hainaut and Strasbourg did not participate in this part of the study. A questionnaire on diagnostic 
details, treatment type and family history of each infant was completed by the local registry based on 
medical records.   
 
Data analysis 
Total prevalence of congenital clubfoot was calculated by the total number of infants and fetuses 
with clubfoot divided by total births (live and stillbirths). Analysis of annual trends in the prevalence 
of clubfoot (non-chromosomal and isolated) was conducted using random-effects Poisson regression 
models to take into account the heterogeneity across registries. The number of births was used as 
the “exposure” variable in the Poisson regression model. Year of birth was categorised into the 
following time periods: 1995-1998, 1999-2002, 2003-2005, 2006-2008, 2009-2011. The Poisson 
model presented prevalence rate ratio (PRR) estimates and 95% confidence intervals (CI) relative to 
the 1995-1998 time period.  All analyses were performed using STATA, version 13.0 (StataCorp LP, 





During 1995–2011, a total of 5,458 infants and fetuses with congenital clubfoot were reported from 
18 EUROCAT registries giving a total European prevalence of congenital clubfoot of 1.13 per 1000 
births (95% CI 1.10-1.16). There were 5,056 (93%) livebirths, 106 (2%) fetal deaths from 20 weeks 
and 296 (5%) TOPFA. Among livebirths 3,262 were males (65%) and 1,788 were females (35%), giving 
a male: female ratio of 1.8:1.  
After case review/classification there were 4,468 (82%) infants and fetuses with isolated clubfoot , 
591 (11%)   with clubfoot as part of multiple congenital anomalies, 144 (3%) was diagnosed with a   
genetic syndrome, only nine (0.2%) infants and fetuses  were reported as associated with teratogenic 
syndromes and  246 (5%)  had a  chromosomal anomaly. Of the 591 infants and fetuses with 
congenital clubfoot and associated major anomalies, congenital heart defects were most frequently 
associated with congenital clubfoot (n=187, 32%), including 80 with ventricular septal defect (VSD), 
followed by anomalies of the nervous system (n=110, 19%), and urinary anomalies (107, 18%). The 
most common chromosomal anomaly was trisomy 18 (n=111, 2%)) (Table 1).  
 
The overall prevalence of congenital clubfoot without an associated chromosomal anomaly was 1.08 
per 1000 births (95% CI 1.05–1.11) with large regional differences, ranging from 0.44 per 1000 births 
in Tuscany and 0.45 per 1000 births in Basque Country to 1.68 per 1000 births in Wales (Table 2). The 
large regional differences were also seen in the prevalence of isolated congenital clubfoot.  The trend 
analysis showed a statistical significant decreasing trend for both groups after 1999-2002 (Figure 1)  
 
In 22 % (921/4165) of infants and fetuses with congenital clubfoot as the only anomaly and with time 
of diagnosis known, the clubfoot was diagnosed prenatally, with considerable variation between 
registries. The prenatal detection rates  ranged from less than 10% in Antwerp, Cork & Kerry, Mainz, 
Wielkopolska, Zagreb, Norway and Malta to higher than 50% in Paris (57%) and Vaud (51%). The 
prenatal diagnosis increased significantly from 20% in 1999-2002 to 29% in 2009-2011 (P<0.01).  
 
Validation of clubfoot records in EUROCAT 
A total of 308 infants and fetuses with congenital clubfoot were sampled for validation. Of these, a 
questionnaire was completed for 301 infants and fetuses by 16 registries. Of the 301 whose 
questionnaires were completed, medical records were obtained for 184 (61.1%). The verification of 
the diagnosis by medical records varied by registry. All sampled clubfoot cases from Denmark, Mainz 
and Malta were verified by medical records. The sampled clubfoot cases from Emilia Romagna and 
Paris could only be verified by registry data and not by original medical records. 
 
The diagnosis congenital clubfoot was confirmed for 286 out of the 301 infants and fetuses (95%), of 
which 176 were validated by medical records, whereas 110 were based on registry information. Two 
infants had questionable congenital clubfoot and 13 infants did not have congenital clubfoot (four 
from Emilia Romagna, three from Mainz, two from Norway; one infant in four registries). Of the 13  
who did not have the major anomaly congenital clubfoot, nine infants  were confirmed to have other  
anomalies of the feet: one case with talipes calcaneovarus (Q661), one case with talipes varus 
(Q662), two cases with talipes calcaneovalgus (Q664), three cases with talipes valgus (Q666) and two 
cases with postural talipes (Q668). Of the 13 infants who did not have congenital clubfoot, eight 
were verified by medical records (i.e. 4.3% of those verified by medical records). Twelve of the 13 
cases who did not have congenital clubfoot were livebirths and one was a TOPFA.  
Epidemiology data of the validation study are presented in Table 3. No statistically significant 
differences were identified between males and females in terms of laterality, family history of 
congenital clubfoot, proportion isolated, or birth type. Of infants with known clubfoot treatment, the 
majority (94%) were treated with splint/casts/surgery. 
 
Discussion 
This European congenital clubfoot study based on data from 18 EUROCAT registries (1995-2011), 
covering almost 5 million births, found a total of 5,458 infants and fetuses with congenital clubfoot   
and a total prevalence of 1.13 per 1000 births, 1.08 per 1000 for congenital  clubfoot without 
chromosomal anomaly and 0.92 per 1000 births for congenital clubfoot as the only major congenital 
anomaly. We found decreasing trends in the prevalence over the 17 years included in the study. Our 
study showed that 95 % of the infants and fetuses from a validation study of congenital clubfoot 
records in EUROCAT were confirmed as true congenital clubfoot. This is particular importance since 
the reporting of congenital clubfoot can be affected by miscoding of the more common postural 
clubfoot as true congenital clubfoot. 
 
The prevalence of congenital clubfoot in our study was comparable with those observed in other 
European population-based studies: 1.03 per 1000 livebirths in Sicily [Pavone et al, 2012] and 1.1 per 
1000 livebirths in Norway [Dodwell et al, 2015]. However, the recorded prevalence of congenital 
clubfoot in our study was lower compared to 1.4 per 1000 livebirths for isolated congenital clubfoot 
found in a study in Sweden [Wallander et al, 2006], 1.8 per 1000 livebirths for all congenital clubfoot 
cases and 1.1 per 1000 births for isolated congenital clubfoot in a study in Southern Australia [Byron-
Scott et al, 2005], 1.14 per 1000 livebirths for isolated congenital clubfoot in Iowa [Kancherla et al, 
2010] and 1.29 per 1000 livebirths pooling 10 birth defects surveillance programs in the US [Parker et 
al, 2009]. The lower prevalence of congenital clubfoot in our study might be partly due to the 
exclusion of secondary clubfoot associated with NTD or bilateral renal agenesis, postural clubfoot 
and other subtypes of foot anomalies in our data.  
 
The overall prevalence of congenital clubfoot varied more than threefold among  registries in our 
study. The large regional differences were also found in isolated congenital clubfoot. There may be 
differences in case ascertainment and also underreporting among registries with the lowest 
prevalence, which may account for the varied prevalence. However, the regional differences in 
prevalence of congenital clubfoot might also reflect a true difference. Other studies have observed 
differences in prevalence of congenital clubfoot based on ethnic groups and region of residence 
[Parker et al, 2009; Moorthi et al, 2005; Wallander et al, 2006].  
 
The observed decrease in the prevalence of congenital clubfoot may be a true decrease, but may also 
be explained by changes in the EUROCAT coding guidelines in 2002 with more focus on excluding 
postural clubfoot as a minor anomaly. The validation study from the more recent period of the study 
(2005-2009) showed that 95% of our cases from these years were true congenital clubfoot. 
 
Our study supported previously reported findings that males were more commonly affected by 
congenital clubfoot.   EUROCAT data lacked complete information on laterality, but the profile from 
the random sample in the validation study was in agreement with other descriptive studies: 
approximately half of confirmed congenital clubfoot cases were bilateral and a right-sided was 
predominant among unilateral clubfoot [Kancherla et al, 2010; Roye et al, 2004]. Congenital clubfoot 
is known to recur in some families [Cardy et al, 2007; Cardy et al 2011]. In the random sample, nine 
percent of the infants and fetuses with congenital clubfoot had a family history, mainly with a first-
degree relative affected, and this can be considered a minimum estimate. This corresponds with 
previous studies showing 7-21% of patients with congenital clubfoot having an affected relative and 
is in line with the multifactorial type of inheritance (Alvarado et al, 2016]. 
 
Several theories on the causes of congenital clubfoot have been proposed, although the exact 
etiology has not been established: restriction of the uterus in early pregnancy, disturbance of 
endochondral ossification of the foot, occurrence secondarily to neurological abnormalities or a 
connective tissue disorder, and vascular disruption [Miedzybrodzka, 2003]. Studies have consistently 
shown an association between maternal smoking and increased risk of congenital clubfoot 
[Kancherla et al, 2010; Werler et al, 2015]. A number of other environmental risk factors and medical 
conditions have been related to the risk of congenital clubfoot in some studies, but not in others, 
including maternal age, parity, education level [Parker et al, 2009; Hollier et al, 2000], solvent 
exposure (including paint-thinner, paint-lacquer-glue remover, and others, e.g., turpentine, toluene, 
carbon tetrachloride) [Dodwell et al, 2015], high levels of alcohol and coffee intake [Miedzybrodzka 
et al, 2003] and maternal obesity [Werler et al, 2013]. Recently, several studies have investigated the 
association between medication use in pregnancy and risk of congenital clubfoot. In a population-
based case-control study conducted in the USA, the risk of congenital clubfoot was associated with 
the use of antiviral drugs (odds ratio (OR) 4.2, 95% CI 1.5-11.7) [Werler et al, 2013] and the use of 
SSRI (OR 1.8, 95% CI 1.1-2.8) [Yazdy et al, 2014]. A significant increased risk of congenital clubfoot 
among SSRI-exposed women was not found in a Danish study (OR 1.3, 95% CI 0.9-2.0) [Henriksen et 
al, 2015]. A case malformed-control study using the EUROCAT database showed that the use of SSRI 
was related to the risk of congenital clubfoot (OR=2.4, 95% CI 1.6-3.7) [Wemakor et al, 2015]. Dolk et 
al. showed an excess risk of congenital clubfoot in relation to lamotrigine exposure using EUROCAT 
database (including the same 18 registries as our current study) [Dolk et al, 2008] although the 
excess risk was not statistically significant in the independent updated dataset from the EUROCAT 
database [Dolk et al, 2016].   
 
Congenital clubfoot has been diagnosed prenatally as early as GA 12 weeks by ultrasound [Keret et 
al, 2002] and therefore detectable by the malformation screening scans usually carried out at GA 18-
22 weeks in most European countries.  In our study, the prenatal detection rate of isolated 
congenital clubfoot improved during the study period. The increase in prenatal diagnosis of 
congenital clubfoot was also observed in Norway during 1987- 2004 [Offerdal et al, 2007] and in 
Tuscany in the period of 1991-2011 [Seravalli et al, 2015].  In Wales, routine fetal anomaly scans are 
part of the antenatal screening program, but these no longer include antenatal detection of 
specifically clubfoot. The variance of antenatal detection rates between registries might be due to 
the different policies regarding purpose and timing of the antenatal routine ultrasound screening in 
each country. 
 
Most epidemiological studies are based on isolated congenital clubfoot. Our study found that more 
than 80% were classified as isolated congenital clubfoot, which was higher than 59.5% in the South 
Australia study [Byron-Scott et al, 2005]. The difference may be mainly due to the exclusion of 
secondary clubfoot associated with renal agenesis, neural tube defects and arthrogryposis multiplex 
congenita in our study.  Among infants and fetuses with congenital clubfoot and associated major 
anomalies, the most common associated anomalies were congenital heart defects with ventricular 
septal defects being most frequent. Comparable with the study in South Australia, trisomy 18 was 
the most common chromosomal anomaly associated with congenital clubfoot.  
 
A strength of the current study is the use of the EUROCAT database, which is a population-based 
European surveillance of congenital anomalies with inclusion of all types of births and all major 
congenital anomalies without bias for inclusion of congenital clubfoot.  The EUROCAT database 
covers a large geographically defined study population, and the well-validated and standardized 
diagnostic information on all types of congenital anomalies. Multiple sources of ascertainment of 
cases are used to avoid ascertainment-bias from specialized centers. Our study had a large sample 
size of almost 5500 cases over a long time period from a total of 4.8 million births. Another strength 
of our study is the exclusion of other subtypes of foot anomalies or postural clubfoot, which avoids 
the potential misclassification of the cases when examining the risk factors of congenital clubfoot. 
We recommend that etiological studies should report their prevalence rate of congenital clubfoot so 
that extent of bias due to potential misclassification of postural clubfoot can be estimated.  
The limitation of our study is the combination of data from different registries with different data-
coding practices and variable case ascertainment. We took some of these heterogeneities across 
registries by using random-effects models that at least to some extent take differences across 
registries into account. We were not able to examine some potential risk factors of congenital 
clubfoot, such as smoking, which are not included in the routine EUROCAT data collection. 
 
In conclusion, we have established a well validated prevalence rate of congenital clubfoot in Europe 
at close to one per 1,000 births, a prevalence of a similar order to some of the other more common 
congenital anomalies such as orofacial clefts and neural tube defects. This can be used as a baseline 
expected prevalence for studies of the effect of medication during pregnancy and other risk factors 
on outcome, but geographical variation in prevalence also needs to be taken into account. During the 
study period, the minority of cases were diagnosed prenatally. While the observed decrease in 
prevalence of congenital clubfoot is reassuring, further monitoring is required, as well as further 
research to understand the etiology of congenital clubfoot so that true prevention can be achieved. 
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Table 1. Classification of cases with congenital clubfoot and associated major congenital anomalies, 
18 EUROCAT registries, 1995-2011 




      Congenital heart defects 187 
       Ventricular septal defect 80 
 Nervous system 110 
       Hydrocephalus  39 
 Urinary 107 
     Congenital hydronephrosis 31 
 Oral clefts 75 
Genetic syndromes Total N=144 
 22q11.2 microdeletion 14 
 Pena-Shokeir syndrome type I 13 
Teratogenic syndromes Total N=9 
Chromosomal Total N=246 
 Edwards syndrome /trisomy 18 101 
 Down syndrome/trisomy 21 48 








Table 2 Prevalence per 1000 births of congenital clubfoot cases without chromosomal anomaly and 
congenital clubfoot cases without associated anomalies (isolated cases) in 18 EUROCAT registries, 
1995-2011 
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Table 3. Characteristics of congenital clubfoot cases confirmed in the validation study. Data from 16 
EUROCAT registries1 
 
 Total Male Female 
 N % N % N % 
Confirmed clubfoot       
   Total 286  186 65% 96 34% 
Birth type       
   Livebirth 269 94% 180 97% 89 93% 
   Stillbirth 5 2% 2 1% 3 3% 
   TOPFA  12 4% 4 2% 4 4% 
Malformations       
   Isolated clubfoot 210 75% 141 76% 68 73% 
   Associated with other anomalies 72 25% 44 24% 25 27% 
   Unknown due to termination 4  0  3  
Laterality       
   Bilateral 158 57% 105 58% 50 56% 
   Unilateral 117 43% 76 42% 40 44% 
      left    45    16%   30    16%    14    15% 
      right    65    24%   41    22%    24    25% 
      unilateral, side unknown    7    3%   5    3%    2     2% 
   Unknown 11  5   6  
Surgery/Spint2       
   Yes 168 94% 123 98% 45 87% 
   No 10 6% 3 2% 7 14% 
   Unknown 91  54  37  
Family history of clubfoot       
   Yes 22 9% 14 9% 8 11% 
   No 216 91% 148 91% 68 89% 
   Unknown 48  24  20  
1 registries in Hainault and Strasbourg not included 
2Among livebirth  
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